Cutler Group’s Niagen Bioscience NAGE Stock Holding History

Cutler Group’s Portfolio NAGE Stock Details NAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$62K	Sell	17,900 -8,900	-33%	-$16.5K	0.02%	594
2023 Q4	$38K	Hold	26,800	–	–	﹤0.01%	1614
2023 Q3	$39K	Hold	26,800	–	–	﹤0.01%	1647
2023 Q2	$42K	Hold	26,800	–	–	0.01%	1397
2023 Q1	$41K	Hold	26,800	–	–	﹤0.01%	1478
2022 Q4	$45K	Hold	26,800	–	–	﹤0.01%	1648
2022 Q3	$32K	Hold	26,800	–	–	﹤0.01%	2256
2022 Q2	$44K	Hold	26,800	–	–	﹤0.01%	2033
2022 Q1	$65K	Hold	26,800	–	–	﹤0.01%	2038
2021 Q4	$100K	Hold	26,800	–	–	﹤0.01%	1856
2021 Q3	$168K	Sell	26,800 -4,500	-14%	-$37.1K	0.01%	1494
2021 Q2	$308K	Sell	31,300 -21,912	-41%	-$191K	0.01%	1040
2021 Q1	$497K	Buy	+53,212	New	+$422K	0.02%	731
2020 Q4	–	Sell	-400	Closed	-$1.95K	–	5636
2020 Q3	$1K	Buy	+400	New	+$1.93K	﹤0.01%	4503
2020 Q2	–	Sell	-300	Closed	-$1.34K	–	5018
2020 Q1	$0	Buy	300 +100	+50%	+$384	﹤0.01%	4793
2019 Q4	$0	Buy	+200	New	+$711	﹤0.01%	4745
2019 Q1	–	Sell	-500	Closed	-$1K	–	4894
2018 Q4	$1K	Buy	+500	New	+$1.74K	﹤0.01%	3749
2018 Q2	–	Sell	-600	Closed	-$2.28K	–	5034
2018 Q1	$2K	Sell	600 -300	-33%	-$1.57K	﹤0.01%	3877
2017 Q4	$5K	Buy	+900	New	+$4.86K	﹤0.01%	3691

Other funds holding NAGE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCM

Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return

Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Cutler Group's NAGE Position: Q1 2024 in Review

Cutler Group reduced its Niagen Bioscience (NAGE) stake by 33% in Q1 2024, selling an estimated $16.5K and leaving 17,900 shares worth $62K. The position accounts for 0.02% of the portfolio, ranked #594.

Cutler Group first reported a position in NAGE in Q4 2017 and has held it in 19 quarters since. The position peaked at $497K in Q1 2021. 67 funds tracked by Wall St. Rank hold NAGE as of Q1 2024.

Cutler Group held 17,900 shares of Niagen Bioscience worth $62K as of Q1 2024.
Cutler Group sold 8,900 Niagen Bioscience shares in Q1 2024, an estimated $16.5K.
Niagen Bioscience made up 0.02% of Cutler Group's portfolio in Q1 2024, its #594 holding.
Cutler Group first reported a position in Niagen Bioscience in Q4 2017 and has held it in 19 quarters since.
Cutler Group's Niagen Bioscience position peaked at $497K in Q1 2021.
67 funds tracked by Wall St. Rank held Niagen Bioscience as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.